---
source_pdf: "https://drive.google.com/file/d/1KcTS6taAydU_aRN0Muy6mGBFIz2Dg_Gf/view"
drive_folder: "Research"
type: research

ingested: 2025-12-28
original_filename: "WB HCIT Life Sciences + Pharmacy IT and Services Landscape (Summer 2021) (1) (2) (1) (3).pdf"
---

> **Original:** [View Original PDF](https://drive.google.com/file/d/1KcTS6taAydU_aRN0Muy6mGBFIz2Dg_Gf/view)

# William Blair
# Life Sciences / Pharmacy IT and Services Landscape
## HCIT Investment Banking Practice
Summer 2021

## About William Blair Healthcare Technology Investment Banking
### William Blair Life Sciences IT Contact Information

**Jeff Dorsheimer**
Managing Director
jdorsheimer@williamblair.com
(617) 235-7548

**Alex Quinn**
Vice President
aquinn@williamblair.com
(617) 235-7584

### William Blair Healthcare Technology Investment Banking
We are the most active HCIT M&A advisor in the market, with unmatched current momentum

*   **6** Senior Bankers Covering the HCIT Sub-Sector Landscape
*   **216** Closed HCIT Transactions Since 1999
*   **7.2x** Average Revenue Multiple in HCIT Sell-Side M&A Since 2015
*   **19.5x** Average EBITDA Multiple in HCIT Sell-Side M&A Since 2015
*   **16** Average Annual HCIT Transactions Since 2015
*   **$55B** In HCIT Transaction Value Since 2015

| Company | Transaction Type | Description | Date |
| :----------------------- | :--------------------------- | :------------------------------------------- | :--------- |
| THOMABRAVO | Agreed to Acquire | greenphire | Pending |
| Transaction Data Systems | Acquired by | BlackRock | May 2021 |
| APTITUDE HEALTH | Acquired by | LINDEN | May 2021 |
| MMIT | Acquired | The Dedham Group | April 2021 |
| OptimizeRx | Follow-On Offering | $75,425,625 | February 2021 |
| Sparta Systems | Acquired by | Honeywell | $1,300,000,000 | February 2021 |
| CERTARA | Initial Public Offering | $772,644,750 | December 2020 |

### Disclosure
These materials are intended solely for the recipient for informational purposes and are of a proprietary nature. William Blair makes no representation or warranty, expressed or implied, as to the accuracy or completeness of the information contained in these materials. The materials do not constitute and should not be considered as any form of financial opinion or recommendation and should not be used to form the basis of any investment decision. The materials may not be used, disclosed, reproduced, summarized or quoted, in whole or in part, without the express written consent of William Blair.

Sources: Pitchbook, CapIQ, Mergermarket, company websites, press releases, and William Blair proprietary intel.

William Blair | 1

# Life Sciences / Pharmacy IT and Services Landscape
## Clinical Trial-Related Software and Tech-Enabled Services
### Clinical Trial-Related Software and Tech-Enabled Services - Segmented

**Clinical Trial-Related Software and Tech-Enabled Services**
*   **4G**
*   **AB-Cube**
*   **adaptive)(clinical**
*   **AADVERA**
*   **ADVARRA**
*   **AGMednet**
*   **anju**
*   **antidote**
*   **aparito**
*   **ArcheMedx**
*   **ArisGlobal**
*   **axiêm**
*   **Be the Partner**
*   **BIOCLINICA**
*   **BRACKENDATA**
*   **BrightInsight>>>>**
*   **Brite Health**
*   **CALYX**
*   **castor**
*   **CRCUIT**
*   **Citruslabs**
*   **Clara**
*   **CLARINESS**
*   **clinCapture**
*   **Clincierge**
*   **Clinical Ink**
*   **ClinicalConnection**
*   **CLINERION**
*   **Cliniops**
*   **ClinOne**
*   **CLINPAL**
*   **CX**
*   **CluePoints**
*   **Commonweal**
*   **Commonwealth**
*   **Complion.**
*   **CONSILX**
*   **CRIO**
*   **CRScube**
*   **crucial**
*   **Curebase**
*   **Cytel:**
*   **DACIMA**
*   **DarkMatter2bd, LLC**
*   **Datacubed**
*   **Data MATRIX**
*   **Datatrial**
*   **DEEP 6 AI**
*   **deep lens**
*   **DELVEHEALTH**
*   **dfnet**
*   **doLoopTech**
*   **dsg**
*   **eClinical**
*   **ELLIGO**
*   **emerging med**
*   **EmpiraMed**
*   **endpoint**
*   **ENNOV**
*   **ENVISION PHARMA GROUP**
*   **ERT**
*   **ETHICAL**
*   **evidation**
*   **EXTEDO**
*   **FindMeCure**
*   **Florence**
*   **formedix**
*   **greenphire**
*   **HUMA**
*   **inato**
*   **Inspire**
*   **inteliquet**
*   **INTRINSIC**
*   **IPSORY**
*   **IQVIA**
*   **JAVARA**
*   **Kayentis**
*   **k koneksa**
*   **Lightship**
*   **MANA RBM**
*   **MASSIVEBIO**
*   **medadata/35**
*   **MEDnet**
*   **medrio**
*   **MEDSCINET**
*   **Mendel.ai**
*   **mosioClin**
*   **MyMeds&Me.**
*   **myTomorrows**
*   **OpenClinica**
*   **ORACLE LIFE SCIENCES**
*   **PARALLEL6/**
*   **PatchAi**
*   **patientwing**
*   **PHLEXGLOBAL**
*   **PINNACLE 21**
*   **PREVAIL**
*   **Pro-ficiency**
*   **Proof Pilot**
*   **protocols.io**
*   **Protocol First**
*   **QureTEC**
*   **R**
*   **REALTIME**
*   **REDCAP**
*   **reify**
*   **REMARQUE**
*   **RxE2**
*   **RLogix**
*   **saama/comprehend**
*   **Science 37**
*   **ScienceMedia**
*   **S-CLINICA**
*   **SIGNALPATH**
*   **SimpleTrials**
*   **SLOPE**
*   **STUDXIK**
*   **SubjectWell**
*   **SureClinical**
*   **suvoda**
*   **teckro.**
*   **thought sphere**
*   **THREAD**
*   **transparency life sciences**
*   **TrialAssure**
*   **trialbee**
*   **Trial/ectory**
*   **trials.ai**
*   **Trial Scope**
*   **TrialSpark**
*   **Trialx**
*   **TriNetX**
*   **TRI**
*   **UMed**
*   **umotif**
*   **UNLEARN**
*   **Veeva**
*   **VeraSci**
*   **Viedoc**
*   **VITA DATA SCIENCES**
*   **wcg**
*   **yprime**

## RWE / Data / Analytics
*   **AETION**
*   **AllStripes**
*   **ANALYTICAL WIZARDS**
*   **Clarivate**
*   **Clinakos**
*   **clinithink**
*   **compile**
*   **ConcertAl**
*   **CONGENICA**
*   **COREVITAS**
*   **COTA**
*   **DNAnexus**
*   **DOCTOR EVIDENCE**
*   **FABRIC**
*   **healthverity**
*   **holmusk**
*   **Insight RX**
*   **inspirata**
*   **KANTAR HEALTH**
*   **komodohealth**
*   **luna**
*   **M2GEN**
*   **MOLECULAR HEALTH**
*   **MOLECULARMATCH**
*   **nference**
*   **OM1.**
*   **OMNY**
*   **Oncora MEDICAL**
*   **ONTOFORCE**
*   **OWKIN**
*   **panalgo**
*   **PHARMASPECTRA**
*   **pieriandx**
*   **PicnicHealth**
*   **PurpleLab**
*   **RData Science®**
*   **SEMALYTIX**
*   **SOPHIA™**
*   **STATinMED**
*   **STRATA**
*   **syapse**
*   **Target RWE**
*   **"T'EMPUS**
*   **TRUVETA**
*   **Verana Health**
*   **Z zymergen**

## Pharma Sales Enhancement
*   **AKTANA**
*   **Apollo Intelligence**
*   **APTITUDE HEALTH**
*   **AXTRIA**
*   **CANCER EXPERT NOW**
*   **CHRONICLED**
*   **Clarify**
*   **ClinicalMind**
*   **closerlook**
*   **conisus**
*   **DEFINITIVE HEALTHCARE**
*   **eightSpokes**
*   **Evaluate**
*   **EVERSANA**
*   **fingerpaint**
*   **FISHAWACK HEALTH**
*   **GMED**
*   **guidemark**
*   **H1.**
*   **Healthcasts**
*   **HealthSTAR Communications**
*   **HMp Global**
*   **HMN**
*   **Honeywell**
*   **Impetus**
*   **Dindegene**
*   **InPharmation**
*   **IntegriChain**
*   **IPD ANALYTICS**
*   **kaizen**
*   **Lockwood**
*   **LUCID GROUP**
*   **thelynxgroup**
*   **medical knowledge group**
*   **MESMERIZE**
*   **MNG Health**
*   **Model N**
*   **myHealthTeams**
*   **OPEN HEALTH**
*   **P360**
*   **PatientPoint**
*   **patientslikeme**
*   **PharmaDemonstration**
*   **Pharma intelligence**
*   **POPULUS**
*   **Prescient Healthcare Group**
*   **PRIME GLOBAL**
*   **prognos**
*   **PULSEPOINT**
*   **REAL CHEMISTRY**
*   **red nucleus**
*   **TI Health**
*   **TRINITY**
*   **USHealthConnect Inc.**
*   **Vodori**
*   **Within3**

## Drug Research & Development
*   **Atomwise**
*   **Benchling**
*   **BenchSci**
*   **BenevolentAI**
*   **CERTARA**
*   **ChemAxon**
*   **Chemical Computing Group**
*   **CDD.**
*   **Exscientia**
*   **FLYWHEEL**
*   **GNS HEALTHCARE**
*   **IKTOS**
*   **Insightful Science**
*   **INSILICO MEDICINE**
*   **insitro**
*   **ISPECIMEN**
*   **labarchives**
*   **NURITAS**
*   **PAIGE**
*   **PathAl**
*   **PROSCIA**
*   **Riffyn**
*   **SCHRÖDINGER.**
*   **Science EXCHANGE**
*   **scientist**
*   **S+ SimulationsPlus**
*   **tetrascience**
*   **VALO HEALTH**

## Pharma Supply Chain
*   **APPRENTICE**
*   **KALLIK**
*   **Knipper**
*   **MEDISPEND**
*   **PARCELSHIELD**
*   **Perigord**
*   **Qualio**
*   **TrakCel**
*   **tracelink**
*   **VALGENESIS**
*   **Veratrak**
*   **Vineti**

## Pharmacy Software and Services
*   **alto**
*   **aspen RxHealth**
*   **BestRx PHARMACY SOFTWARE**
*   **CAPSULE**
*   **CaptureRx**
*   **CarePoint**
*   **DrFirst**
*   **DIGITAL PHARMACIST**
*   **EQUISCRIPT**
*   **FDS**
*   **HealNow**
*   **kalderos**
*   **KITCHECK**
*   **Liberty**
*   **Nimble**
*   **NowRx**
*   **nuvem**
*   **OmniSYS**
*   **Pharmetika**
*   **RedSail TECHNOLOGIES™**
*   **RStrategies™**
*   **RXREVU**
*   **sentry data systems**
*   **Transaction Data Systems**
*   **trc**
*   **Truepill**

## Rx Adherence and Access
*   **ACTIVERADAR**
*   **Adhere Health**
*   **AiCure**
*   **AAPPIANR**
*   **aprexís**
*   **asembia**
*   **AssistRx**
*   **Capital Rx**
*   **CareMetx**
*   **CAREPATHrx**
*   **connective**
*   **conversation health**
*   **csshealth**
*   **cureatr**
*   **EmpiRx HEALTH**
*   **GoodRx**
*   **Health Prize**
*   **helparound**
*   **Hippo**
*   **HUMAN CARE SYSTEMS**
*   **IntegriChain**
*   **IPD ANALYTICS**
*   **>NavigatingCancer**
*   **ONCOLOGY ANALYTICS**
*   **OptimizeRx**
*   **PDMI**
*   **PharmaCord**
*   **prescryptive**
*   **RxAnte**
*   **Rx Savings Solutions**
*   **RXSENSE**
*   **SMRT**
*   **TABULARASA HEALTHCARE**
*   **trialcard**

William Blair | 2

## Clinical Trial-Related Software and Tech-Enabled Services – Segmented

Separates chunkier assets vs. tuck-in ideas. Note: Clinical trial landscape largely excludes CROs.

### Large, Multi-Segment Industry Leaders
*   ADVARRA
*   ArisGlobal
*   BIOCLINICA
*   CALYX
*   ERT
*   IQVIA
*   medidata/35
*   ORACLE LIFE SCIENCES
*   DASSAULT SYSTEMES SEE MORE CLEARLY
*   SIGNANT HEALTH
*   Veeva
*   wcg

### Trial / Protocol Design
*   Cytel
*   Viedoc
*   CLINERION
*   Roof Work Dara Jeuteng
*   FindMeCure
*   formedix
*   evidation
*   protocols.io
*   trials.al
*   UNLEARN

### RTSM / IWRS / IRT
*   endpoint
*   medrio
*   OpenClinica
*   yprime
*   SLOPE
*   suvoda
*   Viedoc

### End-to-End eClinical Solutions
*   anju
*   axiom
*   EVIDENTIO
*   clinCapture
*   real-time metrics
*   Clinical Research
*   CRScube
*   crucial:
*   DACIMA
*   Data MATRIX
*   ENNOV
*   CLIMEAL

### EDC, ePRO, eCOA, and/or eSource
*   Clinical Ink
*   medrio
*   VeraSci
*   Viedoc
*   yprime
*   aparito
*   castor
*   Datatrial
*   dinet
*   dsg
*   CLIRINX
*   koneksa
*   MEDnet
*   MEDSCINET?
*   OpenClinica
*   Kayentis
*   Protocol First
*   QureTEC
*   umotif

### Patient / Site Recruitment
*   antidote
*   CONTINUUM CLINICAL
*   DEEP 6 AI
*   ELLIGO
*   myTomorrows
*   PARALLEL6/*
*   STUDXIK
*   TrialSpark
*   TriNetX
*   aspeninsights
*   CIRCUIT
*   Citruslabs
*   Clara
*   CLARINESS
*   CLINERION
*   Roof Vorik Dara Soutons
*   ClinicalConnection
*   DarkMatter2bd
*   deep
*   emerging med
*   FindMeCure
*   inato
*   Inspire
*   inteliquet
*   JAVARA
*   MASSIVEBIO
*   Mendel.ai
*   patientwing
*   reify
*   SubjectWell
*   TrialVectory

### CTMS / Trial Admin
*   greenphire
*   MEDnet
*   SIGNALPATH
*   teckro.
*   Viedoc
*   Clincierge
*   CRIO
*   EVIDENTIO
*   clinicalresearch
*   INTRINSIC
*   CNICAL SYSTEMS
*   JAVARA
*   Analytics Software. Solutions.
*   R
*   REALTIME
*   SimpleTrials
*   SureClinical
*   thought sphere

### Hybrid Trials
*   MEDABLEX
*   Science 37
*   CLINPAL
*   CliniOps
*   Curebase
*   EmpiraMed
*   HUMA
*   Lightship
*   Proof Pilot
*   Pro-ficiency
*   REDCAP
*   RXE2
*   THREAD
*   transparency
*   umotif
*   UNLEARN

### Patient Engagement
*   PARALLEL6/
*   Be the Partner
*   Brite Health
*   Clincierge
*   ClinOne
*   Datacubed Health
*   di
*   DELVEHEALTH
*   medaptive health
*   mosio
*   PatchAi

### Clinical Analytics
*   Commonwealth Informatics
*   genpact
*   Cytel
*   evidation
*   saama/comprehend
*   VITA DATA SCIENCES
*   BRACKENDATA
*   doLoopTech
*   Evidence OWORKS
*   PINNACLE 21
*   PREVAIL
*   thought sphere

### Safety / Pharmacovigilance
*   Commonwealth Informatics
*   genpact
*   AB-Cube
*   AADVERA
*   EXTEDO
*   Regulatory Affairs
*   MyMeds&Me
*   Ra Logix

### Compliance, eTMF, Regulatory, and/or Quality
*   medrio
*   PHLEXGLOBAL
*   AGMednet
*   ArcheMedX
*   Cyntegrity
*   Complion.
*   Datatrial
*   ETHICAL
*   Florence
*   Kayentis
*   @lin
*   Science Media
*   SureClinical
*   TrialAssure
*   re
*   Trial Scope

### Interoperability / Connectivity
*   adaptive)(clinical
*   AGMednet
*   BrightInsight>>>>>>
*   CONSILX
*   LIFE SCIENCES ON BLOCKCHAIN
*   REMARQUE
*   systems

### Risk-Based Monitoring
*   eeClinical Solutions
*   Cyntegrity
*   CluePoints
*   REMARQUE systems
*   thought sphere
*   MANA RBM

### Other
*   IPSORY EFFICIENT CLINICAL TRIALS
*   Prescient Healthcare Group
*   ENVISION PHARMA GROUP

William Blair | 3

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **4G CLIMEAL** | Cloud-based RTSM, clinical demand, and supply planning software | Schooner Capital, Migration Capital | $30M | $15M (Nov-19) | N/A | |
| **AB-Cube** | Cloud-based pharmacovigilance and safety database software | N/A | N/A | N/A | N/A | |
| **adaptive)(clinical** | Data interoperability software for clinical trials | N/A | N/A | N/A | N/A | |
| **ADVARRA** | IRB, institutional biosafety committee, and research compliance solutions | Genstar | N/A | $1,300M EV (Jul-19) | LBO | PE |
| **ADVERA HEALTH ANALYTICS** | Cloud-based drug safety data, analytics, and signal detection platform | Undisclosed Investors | $3M | $1M (Nov-18) | N/A | VC |
| **AG Mednet** | Cloud compliance solutions for image management, endpoint, and adjudication workflows | N/A | N/A | N/A | N/A | |
| **anju** | Clinical trial efficiency (CTMS, eTMF, EDC) and medical affairs software | ABRY Partners | N/A | ND (Feb-19) | Recap | PE |
| **antidote** | AI-based platform matching patients with current clinical trials | Smedvig Capital, Octopus Investments, Merck GHIF | $37M | ND (Jun-20) | N/A | VC |
| **aparito** | ePRO mobile app and analytics platform for rare disease drug development | Undisclosed Investors | $3M | $2M (Apr-19) | 2019-$6M | VC |
| **ArcheMedX** | Interactive online operational training modules for clinical trial sites | Regeneron Pharmaceuticals, Sanofi | $3M | $3M (Jun-17) | 2017-$12M | |
| **ArisGlobal** | Diversified software provider for drug development | Nordic Capital | N/A | ND (May-21) | PE Growth | PE |
| **axiom** | AI-enabled patient recruitment and matching software for clinical trials | N/A | N/A | N/A | N/A | |
| **Be the Partner** | Unified eClinical software solutions and services (CTMS, EDC, ePRO, ETMF, IWRS) | Great Point Partners | N/A | ND (May-19) | Recap | PE |
| **BIOCLINICA SEE MORE CLEARLY** | Provider of diversified technology solutions for CROs | ERT | N/A | ND (Dec-20) | Acquired | PE |
| **BRACKENDATA** | Clinical trial market intelligence and analytics services | N/A | N/A | N/A | N/A | |
| **BrightInsight>>>>** | Synthesizes clinical data gathered from IoT devices | General Catalyst, Insight, New Leaf, Eclipse Venture | $166M | $101M (Mar-21) | N/A | VC |
| **Brite Health** | Utilizes behavioral and social data to customize patient engagement programs | SAP.IO Foundry | N/A | N/A | N/A | |
| **CALYX** | Multi-segment technology offering for clinical trials (Imaging, CTMS, IRT, RIM, EDC) | Pamplona Capital | N/A | ND (Jan-21) | Spinout | PE |
| **castor** | EDC, ePRO, eCOA, eTMF and eCRF tools for clinical trials | Two Sigma, INKEF Capital, Horizon 2020 | $18M | $12M (Aug-20) | N/A | VC |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 4

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **CIRCUIT** | Clinical trial patient recruitment platform that incorporates ratings and reviews | Western New York Venture, KMG Capital | $18M | $8M (Mar-21) | N/A | VC |
| **Citruslabs** | Clinical trial patient recruitment and retention platform | One Way Ventures, PLG Ventures, 2048 Ventures | $5M | $3M (May-19) | 2018-$7M | VC |
| **Clara** | Patient-centric platform to ease access to clinical trials | Rough Draft Ventures, Abstract Ventures | $14M | $11M (Apr-20) | 2020-$45M | VC |
| **CLARINESS** | Clinical trial patient recruitment and management platform | N/A | N/A | N/A | N/A | |
| **clinCapture** | EDC, eCOA, ePRO, CTMS, and clinical analytics | Rock Health, Healthy Ventures | $3M | $2M (Mar-18) | 2018-$11M | VC |
| **Clincierge** | Clinical trial patient reimbursement and travel logistics services | N/A | N/A | N/A | N/A | |
| **CLINERION** | Uses RWE to help providers match patients with experimental treatments | Undisclosed Investors | N/A | ND (May-17) | N/A | VC |
| **Clinical Ink** | Clinical trial data capture software (EDC, eCOA, ePRO, eSource) | GI Partners, McKesson Ventures | N/A | ND (Aug-20) | LBO | PE |
| **ClinicalConnection** | Clinical trial portal provides a suite of patient recruitment services | N/A | N/A | N/A | N/A | |
| **CRIO** | CTMS, eSource, trial payments, and regulatory compliance software | Rally Ventures, NXT Ventures | $6M | $4M (Mar-21) | N/A | VC |
| **Cliniops** | Clinical trial analytics suite with EDC, ePRO, and eSource tools | N/A | N/A | N/A | N/A | |
| **ClinOne** | Patient engagement, educational content, and digital concierge | Hilltop Ventures, University of Colorado | $7M | $4M (Mar-20) | N/A | VC |
| **CLINPAL** | EDC, ePRO, eCOA, and patient recruitment and engagement software | Undisclosed Investors | $7M | $1M (Oct-18) | 2018-$7M | VC |
| **CX CLIRINX** | EDC tools and outsourced clinical research focused in epilepsy and rare diseases | N/A | N/A | N/A | N/A | |
| **CluePoints** | Risk-based monitoring and quality management software | Summit Partners, Groupe Nivelinvest | N/A | ND (Sep-20) | N/A | PE |
| **Commonwealth Informatics** | Cloud-based clinical data analytics and pharmacovigilance software | Genpact (NYSE:G) | N/A | ND (Jun-18) | N/A | |
| **Complion.** | eRegulatory solution for electronic, audit-ready trial records and signatures | Beringea, JumpStart Ventures | $13M | $7M (Feb-19) | 2019-$22M | VC |
| **CONSILX** | Blockchain-based CTMS and data sharing platform for trial stakeholders | N/A | N/A | N/A | N/A | |
| **CONTINUUM CLINICAL** | Clinical trial recruitment and patient enrollment solutions | Blue Chip Worldwide | N/A | N/A | N/A | |
| **CRScube** | eClinical trial software (EDC, eTMF, CTMS, ePRO, RBM, IWRS) | N/A | N/A | N/A | N/A | |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 5

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **crucial** | Mobile applications for ePRO and EDC | N/A | N/A | N/A | N/A | |
| **Curebase** | Decentralized clinical trial management software | GGV Capital, Pioneer Fund, Xfund, Bold Capital | $18M | $15M (May-21) | N/A | VC |
| **Cyntegrity** | Risk-based quality management (RBQM) technology and services for clinical trials | N/A | N/A | N/A | N/A | |
| **Cytel** | Strategic consulting and software solutions for clinical trial design | Nordic Capital, Astorg | N/A | ND (Dec-20) | LBO | PE |
| **DACIMA** | EDC for clinical trials and patient registries | N/A | N/A | N/A | N/A | |
| **DarkMatter2bd, LLC** | Patient and investigator recruitment and KOL / HCP databases | N/A | N/A | N/A | N/A | |
| **Datacubed Health** | SaaS eCOA platform driven by behavioral sciences | Sterling Partners | $30M | ND (Sep-20) | N/A | PE |
| **Data MATRIX** | EDC, ePRO, IWRS and randomization for trials | Primer Capital | $3M | $3M (Dec-16) | N/A | VC |
| **Datatrial** | Clinical trial document management and data capture software (eTMF, EDC) | N/A | N/A | ND (Jul-16) | LBO | PE |
| **DEEP 6 AI** | AI-based software for clinical trial patient identification and recruiting | Point72 Ventures, Cedars-Sinai | $22M | $17M (Nov-19) | 2019-$51M | VC |
| **deep lens** | Cloud-based pathology platform that identifies patients for trials at diagnosis | Northpond Ventures, Sierra Ventures | $17M | $14M (Apr-19) | 2019-$37M | VC |
| **DELVEHEALTH** | Patient recruitment, engagement/retention, and ePRO software | N/A | N/A | N/A | N/A | |
| **dfnet** | Trial data management and analytics technology and consulting services | N/A | N/A | N/A | N/A | |
| **doLoopTech™** | NLP for medical content recommendation | Oracle, Axilor Ventures | N/A | ND (Oct-17) | N/A | |
| **dsg** | EDC and data management software | N/A | N/A | N/A | N/A | |
| **eeClinical Solutions** | Clinical trial data hub and data management platform | Summit Partners | $19M | $19M (Jan-20) | N/A | PE |
| **ELLIGO HEALTH RESEARCH** | Clinical research platform for research site and patient identification | Cerner, PJ Merchant Banking, Hatteras | $86M | $45M (Dec-20) | 2020-$160M | PE |
| **emerging med** | Clinical trial listings and patient calling center | Carebox Health | N/A | N/A | N/A | |
| **EmpiraMed** | Patient registry for linking PROs with real-world evidence on EMRS | N/A | N/A | N/A | N/A | |
| **endpoint** | Clinical trial supply management and patient randomization solutions | Chiltern (Covance) | N/A | ND (Feb-15) | N/A | |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 6

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **ENNOV** | Pharma-focused document sharing and information management software | Windcrest Partners | N/A | N/A | N/A | |
| **ENVISION PHARMA GROUP** | Medical affairs management technology and services | GHO Capital, Mubadala | N/A | ND (Nov-20) | LBO | PE |
| **ERT** | Health outcomes research and tech-enabled data collection services | Astorg, Nordic Capital, Mubadala | N/A | ND (Oct-19) | N/A | PE |
| **ETHICAL** | Process and data management software for endpoint adjudication committees | N/A | N/A | N/A | N/A | |
| **evidation** | Health and measurement company focused on behavioral data | Kaiser Permanente, OMERS, SV Health | $259M | $153M (Mar-21) | N/A | VC |
| **Evidence Partners** | Pharma-focused literature review search engine | N/A | N/A | N/A | N/A | |
| **EVIDENTIO** | Integrated clinical cloud platform (EDC, RBM, ePRO, eTMF, CTMS, RTSM, Payments) | BID Equity | N/A | ND (Feb-21) | LBO | PE |
| **EXTEDO** | Regulatory information management software and PV database | N/A | N/A | N/A | N/A | |
| **FindMeCure** | Clinical trial listing and application website | LAUNCHub, Force Over Mass Capital | $1M | ND (Jul-17) | N/A | VC |
| **Florence** | Workflow automation software for clinical trial documentation | Insight, Bessemer Ventures, Fulcrum Equity | $87M | $80M (May-21) | 2021-$155M | VC |
| **formedix** | Clinical study design, review, and automation software | Undisclosed Investors | $1M | N/A (Oct-12) | N/A | VC |
| **greenphire** | Clinical trial site payment and patient reimbursement solutions | Thoma Bravo | N/A | ND (May-21) | LBO | PE |
| **HUMA** | Real-time data collection for clinical outcomes tracking and drug discovery | Hitachi Ventures, Leaps by Bayer, NWS Holdings, Healthbox, Dale Ventures | $210M | $130M (May-21) | N/A | VC |
| **inato** | Clinical trial site matching and selection software for biopharma and CROs | Obvious Ventures, Cathay Innovation | $16M | $14M (Feb-20) | 2020-$39M | VC |
| **Inspire** | Online patient support communities for chronic conditions | Azoic Ventures | $19M | $3M (Jul-20) | N/A | VC |
| **inteliquet** | Patient-level data and analytics for clinical trial recruitment and study design | N/A | N/A | N/A | N/A | |
| **INTRINSIC** | CTMS, site engagement, and workforce management software | N/A | N/A | N/A | N/A | |
| **IPSORY** | Automated patient expense reimbursement and trial payments software | N/A | N/A | N/A | N/A | |
| **IQVIA** | Pharma informatics, consulting, and CRO services | NYSE: IQV | N/A | ~$56B EV | N/A | P |
| **JAVARA** | Clinical research services and infrastructure to conduct trials at the point-of-care | Undisclosed | $8M | $5M (Aug-20) | 2020-$40M | VC |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 7

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **Kayentis** | eCOA and eConsent form software | Seventure, Innovation Capital, Extens, LBO Fr. | $26M | $8M (Dec-20) | N/A | VC |
| **koneksa health** | Biometric monitoring, EDC, and eCOA SaaS platform | Spring Mountain, Merck GHIF, McKesson Ventures | $17M | $16M (Sep-20) | 2020-$99M | VC |
| **Lightship** | Virtual trial and patient engagement / recruitment platform | McKesson Ventures, Khosla, Marc Benioff | $25M | $20M (Feb-20) | 2020-$70M | VC |
| **MANA RBM** | RBM software with site and patient risk monitoring and assessments | N/A | N/A | N/A | N/A | |
| **MASSIVEBIO** | Oncology-specific clinical trial matching site and patient/oncologist network | Revo Capital, UL Ventures, IPB | $5M | $3M (Oct-20) | 2019-$28M | VC |
| **MEDABLEX** | Digital clinical trial solutions (eCOA, eSource, eConsent, and ePRO) | Sapphire Ventures, GSR Ventures, PPD, HealthX | $221M | $169M (Apr-21) | 2021-$379M | VC |
| **medaptive health** | Patient surveys for trials, post-market monitoring, patient registry, etc. | Pactolus Ventures, Mentors Fund | $1M | $1M (May-19) | N/A | VC |
| **medidata/35** | SaaS-based clinical development solutions | Dassault Systemes | N/A | ~$5,800 EV (Jun-19) | LBO | P |
| **MEDnet** | Cloud-based, all-in-one eClinical platform (EDC, ePRO, CTMS) | Arrowroot Capital, Cohesive Capital Partners | $22M | $17M (Dec-16) | 2016-$26M | PE |
| **medrio** | eClinical solutions for clinical trials (EDC, eConsent, ePRO, RTSM) | Questa Capital | $34M | $30M (May-17) | 2017-$100M | PE |
| **MEDSCINET** | Cloud-based trial data and registry management | N/A | N/A | N/A | N/A | |
| **Mendel.ai** | Oncology-focused real-world evidence for patient matching/recruitment | SOSV, Plug and Play Tech Center, DCM Ventures | N/A | ND (Nov-20) | N/A | VC |
| **mosio** | Patient engagement and secure messaging portal for clinical trials | N/A | N/A | N/A | N/A | |
| **Clin** | Compliance oversight and eTMF software | N/A | N/A | N/A | N/A | |
| **MyMeds&Me.** | Patient support programs and adverse event intake forms for medications | AlbionVC | $3M | $3M (Feb-13) | N/A | VC |
| **myTomorrows** | Experimental treatment advertising and recruitment hub | EQT Ventures, Balderton Capital, Octopus Ventures | $22M | $10M (Jan-17) | N/A | VC |
| **OpenClinica** | ePRO and study management software | N/A | N/A | N/A | N/A | |
| **ORACLE LIFE SCIENCES** | Horizontal ERP which acquired goBalto (site / trial management) | NYSE: ORCL | N/A | ~$250B EV | N/A | P |
| **PARALLEL6/** | Patient enrollment/qualification and engagement software for trials | PRA Health Sciences | N/A | $47M (May-17) | M&A | P |
| **PatchAi** | Virtual assistant software for clinical trial subjects | Avalanche Investments, Healthware Group | $1M | $1M (Jul-19) | N/A | VC |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 8

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **patientwing** | Online clinical trial listing network | Independence Health Group | $1M | $1M (Feb-18) | N/A | VC |
| **PHLEXGLOBAL** | Provider of electronic Trial Master File (eTMF) software and services | Vitruvian Partners | N/A | ~$160M EV (Dec-16) | LBO | PE |
| **PINNACLE 21** | Software and consulting for clinical trial data aggregation and quality mgmt. | N/A | N/A | N/A | N/A | |
| **PREVAIL** | Trial data integration and predictive analytics software | N/A | N/A | N/A | N/A | |
| **Pro-ficiency** | Virtual training and compliance solutions for clinical trial investigators | NovaQuest | $3M | $3M (Feb-21) | N/A | VC |
| **Proof Pilot** | Web-based platform to quickly design, launch and manage longitudinal trials / studies | Blueprint Health, Cue Ball, BR Venture Fund | $2M | $2M (Nov-14) | N/A | VC |
| **Protocol First** | Oncology-specific EDC software | Leukemia & Lymphoma Society | N/A | ND (May-20) | N/A | VC |
| **protocols.io** | Professional network for sharing clinical trial protocols | Undisclosed Investors | $5M | $4M (Jan-20) | 2020-$14M | VC |
| **QureTEC** | CTMS and EDC software with additional disease registries (HIV, cancer, etc.) | N/A | N/A | N/A | N/A | |
| **REALTIME** | Site operations management software (CTMS, eSource, SitePAY, GlobalPAY) | N/A | N/A | N/A | N/A | |
| **REDCAP** | Decentralized clinical trial platform (eRecruitment, eCOA/ePRO, EDC, eConsent) | Undisclosed | $3M | $2M (Jun-18) | 2016-$9M | VC |
| **reify** | Patient identification, pre-screening, and recruitment software | Battery Ventures, Sierra Ventures | $40M | $30M (Aug-20) | 2020-$160M | VC |
| **REMARQUE systems** | Interoperability system for EDC softwares and lab data | N/A | N/A | N/A | N/A | |
| **RxE2** | AI-driven and pharmacist-led decentralized clinical trial platform | N/A | N/A | N/A | N/A | |
| **RLogix** | Pharmacovigilance data analytics software and consulting | N/A | N/A | N/A | N/A | |
| **saama/comprehend** | Clinical, operational, and risk data management and analytics for life sciences | Perceptive Advisors | $76M | $40M (Mar-19) | N/A | VC |
| **Science 37** | Cloud-based patient-centric mobile research platform | LifeSci Acquisition II Corp (NASDAQ: LSAQ) | N/A | $1,050M EV (May-21) | N/A | P |
| **ScienceMedia** | Cloud-based LMS and education library for clinical trial study compliance | Decathlon Capital Partners | $2M | ND (Nov-20) | N/A | VC |
| **S-CLINICA** | IRT, drug supply forecasting, and drug return and destruction software for trials | N/A | N/A | N/A | N/A | |
| **SIGNALPATH** | Site-focused clinical trial management platform (CTMS) | N/A | $35M | $18M (Oct-19) | N/A | VC |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 9

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **SIGNANT HEALTH** | Patient-centric clinical trial technology platform (eCOA, ePRO, IRT) | Genstar, Harvest | N/A | ND (Jan-18) | PE Growth | PE |
| **SimpleTrials** | CTMS with study startup, document management, payments, and other modules | N/A | N/A | N/A | N/A | |
| **SLOPE** | Clinical supply chain software platform | Various Angels | <$1M | <$1M (Feb-17) | N/A | VC |
| **STUDXIK** | Patient recruitment website that builds communities with similar disease states | Kinderhook Industries | N/A | ND (Mar-18) | PE Growth | PE |
| **SubjectWell** | Online patient recruitment and referrals hub for clinical trials | Frontier Venture Capital, Geekdom Fund | $18M | $2M (Oct-20) | N/A | VC |
| **SureClinical** | Secure file sharing, electronic signature, and eTMF software | N/A | N/A | N/A | N/A | |
| **suvoda** | Patient randomization and clinical supply chain management (IRT+TI, DIMS) | LLR Partners | N/A | $40M (Dec-19) | PE Growth | PE |
| **teckro.** | Clinical trial information retrieval software | Northpond, Founders Fund, Sands Capital | $43M | $25M (Jan-19) | N/A | VC |
| **thought sphere** | Data management, site payment, RBM and BI software | Undisclosed Investors | $2M | $2M (Apr-16) | 2016-$9M | VC |
| **THREAD** | Decentralized research platform to remotely capture data from patients and sites | Water Street, JLL | N/A | $50M (Aug-20) | PE Growth | PE |
| **TrialAssure** | Clinical trial disclosures, compliance, and transparency reporting software | N/A | N/A | N/A | N/A | |
| **trialbee** | Clinical trial recruitment and engagement platform | MTIP, Various Angels | $21M | $12M (Apr-20) | N/A | VC |
| **Trial/ectory** | AI-based trial-matching platform for oncology patients and providers | Contour Venture Partners | $9M | $5M (Feb-21) | N/A | VC |
| **trials.ai** | Big data and analytics tools for optimizing trial protocols and design | Growth Technology Partners | $3M | $2M (Jan-21) | N/A | VC |
| **Trial Scope** | Clinical trial recruitment, registration, and disclosure / compliance management | Informa (LON:INF) | N/A | ND (Dec-20) | Acquired | P |
| **TrialSpark** | Network of sites to create trial opportunities for doctors within existing practices | Sequoia Capital, Thrive Capital | $87M | $70M (Oct-18) | 2018-$610M | VC |
| **Trialx** | Patient recruitment management software for clinical trials | N/A | N/A | N/A | N/A | |
| **TriNetX** | RWE network for site and patient recruitment | Carlyle Group | N/A | ND (Sep-20) | LBO | PE |
| **TRI** | Clinical trial risk mgmt. and monitoring tools to mitigate risk from trial start | Octopus Investments | N/A | ND (Oct-18) | N/A | VC |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 10

## Clinical Trial-Related Software and Tech-Enabled Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **UMed** | EHR data-matching platform to efficiently find and recruit patients | AlbionVC, Delin Ventures, Playfair Capital | $6M | $5M (Nov-20) | 2020-$10M | VC |
| **umotif** | eCOA, ePRO, and eConsent and virtual trial data capture software | AlbionVC | $10M | $7M (Sep-20) | 2020-$27M | VC |
| **UNLEARN** | ML platform focused on improving clinical trial execution with digital patient insights | 8VC, Data Collective, Eisai Ventures | $20M | $12M (Nov-20) | 2020-$40M | VC |
| **Veeva** | Diversified cloud software provider for life sciences | NYSE: VEEV | N/A | ~$42B EV | N/A | P |
| **VeraSci** | eCOA platform focused on CNS therapeutic landscape | National Institute on Aging, NIMH | $6M | $5M (Jan-16) | N/A | VC |
| **Viedoc** | EDC, ePRO, eCRF, CTMS and patient management software | Monterro | N/A | ND (Nov-19) | LBO | PE |
| **VITA DATA SCIENCES** | Statistical analysis and data visualization software and IT services | Softworld, Inc. | N/A | N/A | N/A | |
| **wcg** | Clinical trial software/services to reduce cost and time of clinical trials | Leonard Green, Arsenal Capital Partners | N/A | ~$3.1B EV (Nov-19) | LBO | PE |
| **yprime** | Clinical trial software with eCOA and IRT platforms | Flexpoint Ford | N/A | ND (Feb-19) | PE Growth | PE |

Definitions: CTMS = Clinical Trial Management System, eCOA = electronic Clinical Outcomes Assessments, ePRO = electronic Patient Reported Outcome, eTMF = electronic Trial Master File, EDC = electronic data capture, IRB = Institutional Review Board, IRT = Interactive Response Technology, RTSM = Randomization and Trial Supply Management., DIMS = Drug Inventory Management System
: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 11

## Data / Analytics / Insights / Real-World Evidence – Segmented

Separates chunkier assets vs. tuck-in ideas.

### NLP / PubMed-Focused Analytics
*   DOCTOR EVIDENCE
*   komodohealth
*   clinithink
*   nference
*   ONTOFORCE
*   PHARMASPECTRA

### Registries
*   COREVITAS
*   OM1.
*   Target RWE

### Genomic-Focused Analytics
*   M2GEN
*   SOPHIA™
*   Z zymergen
*   CONGENICA
*   FABRIC GENOMICS™
*   luna DNA
*   pieriandx
*   STRATA oncology

### Real-World Evidence Analytics and Services
*   AETION
*   CIox REAL WORLD DATA
*   Clarivate Analytics
*   KANTAR HEALTH
*   panalgo
*   STATinMED
*   syapse
*   Verana Health
*   ANALYTICAL WIZARDS
*   compile
*   COTA
*   holmusk
*   OMNY
*   OWKIN
*   PurpleLab
*   RData Science®
*   SEMALYTIX

### Precision Medicine Analytics
*   ConcertAl
*   DNAnexus
*   "T'EMPUS
*   Clinakos
*   Insight RX
*   inspirata
*   MOLECULAR HEALTH™
*   MOLECULARMATCH
*   Oncora MEDICAL
*   TRUVETA

### Data Marketplace
*   AllStripes
*   healthverity
*   PicnicHealth

William Blair | 12

## Data / Analytics / Insights / Real-World Evidence – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **AETION** | Regulatory-grade real-world evidence platform for life sciences and payers | Warburg Pincus, Foresite Capital, NEA, Flare Capital, McKesson | $204M | $110M (May-21) | N/A | VC |
| **AllStripes** | Aggregates patient clinical data for rare disease drug discovery | Spark Capital, Lux Capital, Maveron Capital | $17M | $14M (Apr-20) | N/A | VC |
| **ANALYTICAL WIZARDS** | Healthcare analytics platform leveraging ML to provide product strategy insights | Sopris Capital | $3M | $3M (Nov-19) | 2019-$13M | VC |
| **ciox REAL WORLD DATA** | RWE analytics with connections to 18k providers and 140+ plans | New Mountain Capital, Merck GHIF | $110M | $30M (Jul-19) | PE Growth | PE |
| **Clarivate Analytics** | Informatics and analytics for scientific research and life sciences markets | NYSE: CLVT | N/A | ~$20B EV | N/A | P |
| **Clinakos** | Patient data (Rx, lab, genomic, EMR, etc.) consolidation / analytics platform | N/A | N/A | N/A | N/A | |
| **clinithink** | AI data platform driving insights from unstructured medical data | Merck GHIF | $41M | $16M (Jan-19) | 2019-$46M | VC |
| **compile** | Platform distilling large data structures into actionable strategic insights for pharma | N/A | N/A | N/A | N/A | |
| **ConcertAl** | Oncology real-world evidence and data analytics platform | SymphonyAI, Declaration Partners | N/A | $150M (Jan-20) | N/A | PE |
| **ICONGENICA** | Genomic data interpretation software | Tencent Holdings, Parkwalk Advisors | $87M | $50M (Nov-20) | 2020-$118M | VC |
| **COREVITAS** | Observational data and RWE platform for autoimmune diseases | Audax Group | N/A | ND (Dec-19) | LBO | PE |
| **COTA** | Oncology data and analytics platform | IQVIA, EW Healthcare, Varian Medical | $105M | $34M (Nov-20) | N/A | PE |
| **DNAnexus** | Data analysis and management platform for DNA sequence data | Northpond Ventures, GV, TPG Growth | $296M | $100M (Jun-20) | 2020-$195M | VC |
| **DOCTOR EVIDENCE** | Data and analytics for evidence-based medicine | N/A | $4M | $2M (Mar-11) | N/A | VC |
| **FABRIC GENOMICS** | Genomics-driven precision medicine software | UPMC, Roche Venture, LDV Partners | $32M | $2M (Dec-19) | N/A | VC |
| **healthverity** | Healthcare and consumer data exchange and interoperability tools | Greycroft, Flare Capital Partners, Foresite Capital | $42M | $25M (Apr-19) | 2019-$125M | VC |
| **holmusk** | Behavioral health-focused RWE database and digital therapeutics | Health Catalyst Capital Management, Optum Ventures | $31M | $22M (Apr-20) | N/A | VC |
| **Insight RX** | Cloud-based clinical decision support tool for use at point-of-care | HealthX | $14M | $10M (Sep-19) | 2019-$32M | VC |
| **inspirata** | Cancer diagnostics and care pathways software | N/A | N/A | N/A | N/A | |
| **KANTAR HEALTH** | RWE and data analytics platform targeting oncology and rare disease product areas | Cerner | N/A | ND (Dec-20) | Acquired | P |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 13

## Data / Analytics / Insights / Real-World Evidence – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **komodohealth** | Geo-spatial mapping for patient outcomes and conditions | Tiger Global, ICONIQ, a16z, Oak HC/FT, Felicis Ventures | $328M | $220M (Mar-21) | 2021-$3.3B | VC |
| **luna DNA** | Genomic and medical research database for use in DNA sequencing | Bain Capital Ventures, F-Prime | $9M | $5M (May-19) | N/A | VC |
| **M2GEN** | Bioinformatics marketplace utilizing data from network of ~20 cancer centers | CD&R, Merck GHIF, McKesson Ventures, Hearst | $100M | $100M (Mar-21) | N/A | PE |
| **MOLECULAR HEALTH** | Computational biomedicine platform for molecular and clinical data analysis | Bill & Melinda Gates Foundation, Hopp BioTech | $78M | $50M (Sep-17) | N/A | VC |
| **MOLECULARMATCH** | Uses patient genetic data to source appropriate therapies | Houston Angel Network | $14M | $1M (Jan-17) | N/A | VC |
| **nference** | NLP for extraction of knowledge from scientific, clinical, etc. datasets | Mayo Clinic, NTT Venture Capital, Matrix Partners | $145M | $61M (Dec-20) | 2020-$861M | VC |
| **OM1.** | Measurement and predictive analytics platform for real-world outcomes | Polaris Partners, General Catalyst | $91M | $50M (Dec-19) | 2019-$280M | VC |
| **OMNY** | Health system and specialty network RWD aggregation tools | SpringRock Bentures, DNA Capital, Social Capital | $6M | $1M (Jul-20) | N/A | VC |
| **Oncora MEDICAL** | Oncology workflow and analytics software that collects and deploys RWD | Varian Medical Systems | $7M | $3M (Sep-19) | N/A | VC |
| **ONTOFORCE** | Health data aggregation software and analytics dashboards for pharma | Kroys Investments | $18M | $5M (Feb-18) | 2018-$13M | VC |
| **OWKIN** | Patient data and analytics for use in commercial drug development | Bpifrance, F-Prime Capital, Eight Roads | $74M | $43M (May-20) | 2020-$215M | VC |
| **panalgo** | Instant health data analytics platform | Silversmith, Transformation Capital | $78M | $78M (May-19) | PE Growth | PE |
| **PHARMASPECTRA** | Medical affairs data analytics tools for pharma | Inflexion | N/A | ND (Oct-19) | LBO | PE |
| **PicnicHealth** | Platform for patients to manage their care and also gives pharma access to the data | Felicis Ventures, Amplify Partners | $35M | $25M (Aug-20) | 2020-$135M | VC |
| **pieriandx** | Clinical genomics software for precision medicine | Health Catalyst Capital Management, SJF, Ventures, ATW Partners | $41M | ND (Aug-20) | N/A | VC |
| **PurpleLab** | Cloud-based analytics platform providing strategic insights based on medical claims data | Edison Partners | $3M | $3M (Jun-19) | 2019-$15M | VC |
| **RData Science®** | Biopharma analytics and data lake platform from phase 2/3 to commercialization | N/A | N/A | N/A | N/A | |
| **SEMALYTIX** | AI-based RWE generation tool ingesting patient forum and social media data | NRW.BANK | $8M | $8M (Feb-21) | N/A | VC |
| **SOPHIA™** | Applies AI to DNA sequencing to enable data driven medicine | aMoon Fund, Generation IM, Balderton Capital | $250M | $110M (Oct-20) | 2020-$565M | VC |
| **STATinMED** | Advanced outcomes research, consulting, and statistical analysis | Ancor Capital Partners | N/A | ND (Sep-18) | LBO | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 14

## Data / Analytics / Insights / Real-World Evidence – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **STRATA oncology** | Precision oncology testing and patient matching services | Pfizer Ventures, Merck Global Health Innovation | $43M | $5M (Nov-20) | 2018-$86M | VC |
| **syapse** | Precision medicine software for cancer care | Amgen Ventures, Medidata, Merck, Roche | $188M | $68M (Feb-21) | N/A | VC |
| **Target RWE** | Real world clinical data and analytics organized around diseases instead of drugs | Norwest Venture Partners | N/A | ND (May-18) | N/A | PE |
| **"T'EMPUS** | Genomic-testing and data-analytics for cancer | NEA, Novo Holdings, T. Rowe Price | $1,050M | $250M (Dec-20) | 2020-$8.1B | VC |
| **TRUVETA** | Patient data and analytics with de-identified data provided by healthcare systems | AdventHealth, Bon Secours Mercy, Northwell Health, Providence | N/A | N/A | N/A | |
| **Verana Health** | Regulatory-grade datasets to optimize clinical trials | Bain Capital Ventures, GE Ventures, GV | $139M | $100M (Feb-20) | 2020-$250M | VC |
| **Z zymergen** | AI-enabled genome mapping | NASDAQ: ZY | N/A | ~$4,400M EV | N/A | P |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 15

## Pharma Sales Enhancement – Segmented

### Salesforce Management and Optimization
*   AKTANA
*   AXTRIA
*   kaizen

### Commercialization Services
*   EVERSANA
*   TRINITY
*   Dindegene

### Condition-Specific Communities
*   health union
*   GMED
*   myHealthTeams
*   patientslikeme

### Marketing and Medical Communications
*   APTITUDE HEALTH
*   cea clinical education alliance
*   closerlook
*   conisus
*   FISHAWACK HEALTH
*   fingerpaint
*   guidemark
*   HealthSTAR Communications
*   H+ huntsworth health
*   THE KINETIK GROUP
*   Lockwood
*   LUCID GROUP
*   thelynxgroup
*   medical knowledge group
*   OPEN HEALTH
*   Pharma Value Demonstration
*   Prescient Healthcare Group
*   PRIME GLOBAL
*   REAL CHEMISTRY
*   CANCER EXPERT NOW
*   ClinicalMind
*   MinStep Health
*   HMP Global
*   MNG Health
*   TI Health

### Market Intelligence / HCP Databases
*   Apollo Intelligence
*   DEFINITIVE HEALTHCARE
*   Evaluate
*   88 MMIT
*   Informa
*   Clarify
*   H1.
*   IPD ANALYTICS
*   MATIRPR
*   PULSEPOINT

### Point of Care Engagement
*   HMN HEALTH Media NETWORK
*   Healthonitor network
*   PatientPoint
*   MESMERIZE
*   P360
*   POPULUS

### Network and Revenue Optimization
*   IntegriChain
*   Model N
*   CHRONICLED
*   InPharmation

### Collaboration Software
*   Within3
*   eightSpokes
*   Healthcasts.
*   Impetus
*   Vodori

### Other
*   prognos
*   red nucleus
*   USHealthConnect Inc.

William Blair | 16

## Pharma Sales and Marketing Enhancement – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **AKTANA** | Decision support platform for commercial drug sales teams | Norwest Venture Partners, Transformation Capital | $113M | $30M (Oct-20) | 2020-$150M | VC |
| **Apollo Intelligence** | Tech-driven analytics and info services for life science research & marketing teams | Saroras Private Capital | N/A | ND (Aug-19) | LBO | PE |
| **APTITUDE HEALTH** | Info services from expert network for pharma's strategies in oncology / hematology | Linden Capital | N/A | ND (May-21) | LBO | PE |
| **AXTRIA** | Commercial-focused big data analytics software and services | Founders, Bain Capital Tech Opportunities, Helion Ventures | $214M | $150M (May-21) | 2021-$1B | VC |
| **CANCER EXPERT NOW** | Oncology-focused communication platform connecting oncologists and patients directly | N/A | N/A | N/A | N/A | |
| **CHRONICLED** | Blockchain-based track-and-trace software for pharma supply chains | Streamlined Ventures, Oregon Enterprise Blockchain Venture | $28M | $6M (Dec-19) | 2019-$56M | VC |
| **Clarify** | Longitudinal patient and provider data / analytics to craft commercial strategies | Undisclosed Investors | $101M | $13M (Apr-20) | 2020-$213M | VC |
| **cea clinical education alliance** | Develops live and virtual personalized and moderated continuing medical education | Riverside Company | N/A | ND (Dec-20) | LBO | PE |
| **ClinicalMind** | Pharma marketing and communications management software and consulting | Renovus Capital Partners | N/A | ND (Nov-19) | LBO | PE |
| **closerlook** | Creates digital advertising and provider engagement campaigns for pharma | N/A | N/A | N/A | N/A | |
| **conisus** | Brand strategy, medical communications, and business intelligence for biopharma | Webster Equity Partners | N/A | ND (Jan-11) | LBO | PE |
| **DEFINITIVE HEALTHCARE** | Commercial intelligence database focused on healthcare providers | Advent International, Spectrum Equity | N/A | ND (Jun-19) | LBO | PE |
| **eightSpokes** | Workforce collaboration software for drug launch processes | N/A | N/A | N/A | N/A | |
| **Evaluate** | Commercial informatics provider for life sciences | HgCapital | N/A | ND (Aug-20) | N/A | PE |
| **EVERSANA** | Comprehensive pharma commercialization services suite | Water Street, JLL | N/A | ND (Oct-18) | N/A | PE |
| **fingerpaint** | Data-driven marketing services for pharma, rare disease, and gene therapy | Knox Lane | N/A | ND (Dec-20) | N/A | PE |
| **FISHAWACK HEALTH** | Commercial consulting and marketing agency services for pharma | Bridgepoint Advisers | N/A | $293M EV (Apr-20) | LBO | PE |
| **GMED** | Online global physicians community crowdsourcing physician real-world experience | N/A | N/A | N/A | N/A | |
| **guidemark** | Multi-channel marketing and engagement services for rare disease and oncology | High Road Capital Partners | N/A | ND (Nov-12) | N/A | PE |
| **H1.** | HCP and medical claims databases for med. affairs and pharma marketing | IVP, Menlo Ventures, Transformation Capital | $71M | $58M (Dec-20) | 2020-$258M | VC |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 17

## Pharma Sales and Marketing Enhancement – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **HMN HEALTH Media NETWORK** | Point of care patient educational content and media company | Saratoga Investment | N/A | $13M (May-14) | N/A | VC |
| **Healtmonitor network** | Point-of-care marketing services | WestView Capital Partners | N/A | ND (May-19) | PE Growth | PE |
| **health union** | Advertising network of online patient communities for chronic conditions | Court Square Capital Partners | N/A | ND (Dec-20) | LBO | PE |
| **Healthcasts.** | Peer-to-peer education platform for physicians | N/A | N/A | N/A | N/A | |
| **HealthSTAR Communications** | Marketing and medical education services for pharma brands | H.I.G. Capital | N/A | $200M EV (Jun-01) | LBO | PE |
| **HMP Global** | Medical communications and marketing firm | Susquehanna Growth Equity | N/A | ND (Dec-15) | LBO | PE |
| **HG huntsworth health** | Marketing and communications agency for pharma | Clayton, Dubilier & Rice | N/A | $714M EV (May-20) | LBO | PE |
| **Impetus** | Collaboration software for clinical trials and pharma marketing campaigns | Canadian Technology Accelerator | N/A | N/A | N/A | |
| **Dindegene** | Builds and manages digital-first workflows to modernize clinical and commercial ops | Carlyle Group, Brighton Park Capital | $200M | $200M (Feb-21) | N/A | PE |
| **InPharmation** | Pharmaceutical market research, pricing and market access services | N/A | N/A | N/A | N/A | |
| **inStep Health.** | Digital and physical marketing network for retail medication | N/A | N/A | N/A | N/A | |
| **IntegriChain** | Data and analytics platform focused on patient therapy access and adherence | Accel-KKR | N/A | ND (Feb-16) | LBO | PE |
| **IPD ANALYTICS** | Drug life cycle analysis leveraging clinical, formulary, and procurement insights | N/A | N/A | N/A | N/A | |
| **kaizen** | Analytics and data platform for pharma commercial sales teams | N/A | N/A | N/A | N/A | |
| **Lockwood** | Marketing and communications solutions for major therapeutic areas and rare disease | N/A | N/A | N/A | N/A | |
| **LUCID GROUP** | Multi-channel HCP marketing and education services for pharmaceutical brands | Intermediate Capital Group | N/A | ND (Mar-21) | LBO | PE |
| **thelynxgroup** | Multi-channel advertising and research publications produced through expert network | N/A | N/A | N/A | N/A | |
| **MATIRPR** | Data and analytics platform focused on payer insights | Silversmith Capital | $30M | $30M (Dec-20) | N/A | PE |
| **medical knowledge group.** | Multi-channel marketing services for pharma brands | Court Square Capital Partners | N/A | ND (Jan-20) | LBO | PE |
| **MESMERIZE** | Specialty point-of-care and out-of-home marketing services | The Beekman Group, Harvest Capital Credit | N/A | $13M (Apr-14) | N/A | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 18

## Pharma Sales and Marketing Enhancement – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **88 MMIT** | Formulary and policy data provider for pharma, payers, and providers | WCAS | N/A | ND (Nov-18) | LBO | PE |
| **MNG Health** | Multi-channel HCP marketing services for pharma and med. device brands | Undisclosed Investors | N/A | ND | LBO | PE |
| **Model N** | RCM software with sales optimization and contract management tools for pharma | NYSE: MODN | N/A | ~$1,450M EV | N/A | P |
| **myHealthTeams** | Social network for patients with chronic conditions | Adams Street, CVS Health, Qiming Venture Partners | $27M | $9M (Aug-19) | 2019-$69M | VC |
| **OPEN HEALTH** | Healthcare communications, HEOR, and market access solutions | Amulet Capital | N/A | ND (Dec-18) | LBO | PE |
| **P360** | Sales enablement and business optimization solutions for life science companies | N/A | N/A | N/A | N/A | |
| **PatientPoint** | Point-of-care patient engagement | L Catterton, Searchlight Capital | $171M | $140M (Jun-17) | N/A | PE |
| **patientslikeme** | Integrated patient health management, communication, and real-world data platform | Alta Partners, Optum Ventures | $150M | $26M (Feb-21) | N/A | VC |
| **PharmaDemonstration** | HEOR, market insights, and scientific communication services to biopharma | Arsenal Capital Partners | N/A | ND (Jun-20) | LBO | PE |
| **Pharma intelligence** | Pharma market intelligence and business development consultancy | Informa (LON:INF) | N/A | ~$15B EV | N/A | P |
| **POPULUS** | Point-of-care patient engagement / advertising through telehealth | N/A | N/A | N/A | N/A | |
| **Prescient Healthcare Group** | Global product strategy advisory services and software serving pharma and biotech | Bridgepoint | N/A | ND (Jan-21) | LBO | PE |
| **PRIME GLOBAL** | Medical communications and market access services for pharmaceutical brands | Levine Leichtman | N/A | ND (Apr-21) | LBO | PE |
| **prognos** | AI-enabled platform for clinical diagnostics information | Merck GHIF, Safeguard Scientifics | $43M | $21M (Nov-17) | 2017-$103M | VC |
| **PULSEPOINT** | Pharma brand advertising and analytics platform | Internet Brands | N/A | ND (Apr-21) | Acquired | PE |
| **REAL CHEMISTRY** | Analytics, market research, and digital / social media services | New Mountain Capital | N/A | ~$625M EV (Jun-19) | LBO | PE |
| **red nucleus** | Pharma educational curricula and games for commercial and staff engagement | The Riverside Company | N/A | $145M EV (Dec-19) | LBO | PE |
| **THE KINETIK GROUP** | Market access and population engagement services for pharma and med device platforms | N/A | N/A | N/A | N/A | |
| **TI Health** | Data-driven marketing services utilizing precision targeting for HCPs and patients | Halyard Capital | N/A | $44M EV (Aug-18) | LBO | PE |
| **TRINITY** | Commercialization strategy and analytics for pharma | Parthenon Capital | N/A | ND (Mar-18) | LBO | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 19

## Pharma Sales and Marketing Enhancement – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **USHealthConnect Inc.** | Digital education strategies and engagement data solutions for pharma | Morgan Stanley Capital Partners | N/A | ND (Oct-20) | LBO | PE |
| **Vodori** | Commercial content collaboration and review software for pharma | Various Angels | $4M | $3M (Apr-20) | N/A | VC |
| **Within3** | Digital collaboration platform to engage healthcare professionals for pharma | Insight Partners, Silversmith Capital | $127M | $100M (Sep-20) | N/A | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 20

## Rx Adherence, Affordability, and Patient Support – Segmented

### Care Management
*   NavigatingCancer
*   ONCOLOGY ANALYTICS

### Hub Services
*   CareMetx
*   connective
*   trialcard
*   AAPPIANR
*   asembia
*   AssistRx
*   helparound
*   HUMAN CARE SYSTEMS
*   PharmaCord

### Medication Therapy Management
*   CAREPATHrx
*   csshealth
*   TABULARASA HEALTH SOLUTIONS
*   Adhere Health
*   aprexís
*   cureatr
*   Medisafe

### Rx Info and Risk Management
*   MedAware
*   TABULARASA HEALTHCARE

### Engagement and Adherence
*   AiCure
*   connective
*   OptimizeRx
*   TABULARASA HEALTHCARE
*   trialcard
*   conversation health
*   Health Prize Technologies
*   helparound
*   Medisafe
*   NavigatingCancer
*   RxAnte
*   SMRT

### PBM-Related
*   EmpiRx HEALTH
*   RXSENSE
*   ACTIVERADAR
*   Capital Rx
*   PDMI
*   Rx Savings Solutions

### Rx Cost Savings
*   connective
*   GoodRx
*   OptimizeRx
*   RXSENSE
*   trialcard
*   Hippo
*   prescryptive

William Blair | 21

## Rx Adherence, Affordability, and Patient Support – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **ACTIVERADAR** | Pharmacy cost reduction programs for employers | Kinderhook Industries | N/A | ND (Feb-16) | LBO | PE |
| **Adhere Health** | Platform for medication therapy management and quality measure improvement | The Riverside Company | $10M | $9M (Dec-09) | N/A | PE |
| **AiCure** | AI recognition app to track medication adherence | Pritzker Group, Baird Capital | $69M | $25M (Nov-19) | N/A | VC |
| **AAPPIANR** | Hub and ML-driven patient support services with 10+ specialty pharmacies | Frazier Healthcare Partners | N/A | ND (Nov-17) | LBO | PE |
| **aprexís** | Medication therapy management software | CMS Group | $5M | $4M (Jun-12) | N/A | VC |
| **asembia** | Specialty pharmacy software and services (purchasing, contracting, HUB services) | N/A | N/A | N/A | N/A | |
| **AssistRx** | Technology for prescribing, distributing, and administering specialty medications | N/A | N/A | N/A | N/A | |
| **Capital Rx** | Pharmacy benefits management technology platform | Transformation Capital, Edison Partners | $69M | $50M (Feb-21) | 2021-$246M | PE |
| **CareMetx** | Cloud-based technology enabling hub services | General Atlantic, Vistria Group | N/A | ND (Jan-21) | LBO | PE |
| **CAREPATHrx** | Enterprise approach to pharmacy care delivery | Nautic Partners, AlpInvest Partners | N/A | ND (Dec-20) | LBO | PE |
| **connective** | Patient Rx assistance and payment reimbursement | Genstar, Blackstone, Harvest Partners | N/A | $300M (Mar-20) | N/A | PE |
| **conversation health** | AI-based chatbot for pharma brands to drive patient engagement and adherence | Plug and Play Tech Center | N/A | N/A | N/A | |
| **csshealth** | Medication therapy management software platform and compliance packaging | HealthEdge, 424 Capital | N/A | ND (Oct-17) | LBO | PE |
| **cureatr** | Medication management platform with real-time Rx data to drive interventions | JMI Invest, Windham Venture | $34M | $11M (Mar-21) | N/A | VC |
| **EmpiRx HEALTH** | Technology-driven risk-based pharmacy benefit manager | N/A | N/A | N/A | N/A | |
| **GoodRx** | Track prescription drug prices and drug coupons | NASDAQ:GDRX | N/A | ~$15B EV | N/A | P |
| **Health Prize Technologies** | Pharma's gamified patient medication adherence platform | Various Angels | $18M | $3M (Nov-20) | N/A | VC |
| **helparound** | Tech-enabled patient onboarding and access solutions for chronic care markets | IQVIA, PharMedQuest, Windham Venture Partners | $11M | $6M (Jan-20) | 2020-$19M | VC |
| **Hippo** | Prescription drug prices and drug coupons | N/A | N/A | N/A | N/A | |
| **HUMAN CARE SYSTEMS** | Cloud-based platform for patient services and adherence communications | N/A | N/A | N/A | N/A | |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 22

## Rx Adherence, Affordability, and Patient Support – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **MedAware** | AI-enabled patient safety platform to identify and prevent medication-related errors | BD, Qure Ventures, Gefen Capital | $10M | $8M (Aug-18) | N/A | VC |
| **Medisafe** | Mobile medication management platform | Sanofi Ventures, M Ventures | $52M | $30M (Feb-21) | N/A | VC |
| **NavigatingCancer** | Patient relationship management platform designed for cancer patients | Merck GHIF, LabCorp | $36M | $26M (Sep-19) | N/A | VC |
| **ONCOLOGY ANALYTICS** | Oncology care plan optimization software for health plans | McKesson Ventures, Oak HC/FT, Baird Capital | $57M | $28M (May-20) | 2020-$103M | PE |
| **OptimizeRx** | Digital health messaging via EHRs | NASDAQ:OPRX | N/A | ~$850M EV | N/A | P |
| **PDMI** | Pharmacy claims processing and administration | N/A | N/A | N/A | N/A | |
| **PharmaCord** | Patient support services and technology for therapy initiation/patient engagement | N/A | N/A | N/A | N/A | |
| **prescryptive** | Prescription intelligence platform for Rx cost transparency/benefit info for patients | Morningside Ventures, SeaChange Fund | $34M | $25M (Sep-20) | 2020-$96M | VC |
| **RxAnte** | Analytics and patient engagement platform to drive medication adherence | UPMC Enterprises, First Trust Capital Partners | $16M | $9M (Nov-20) | 2020-$29M | VC |
| **Rx Savings Solutions** | Pharmacy cost reduction programs for patients and health plans | McCarthy Capital, Cobalt Ventures | $22M | $18M (Nov-17) | PE Growth | PE |
| **RXSENSE** | Platform to improve transparency and increase access to affordable medications | Parthenon Capital | N/A | ND (Mar-20) | PE Growth | PE |
| **SMRT** | Medication adherence and patient engagement | KCRise Fund | $7M | ND (Jul-19) | N/A | VC |
| **TABULARASA HEALTHCARE** | Medication risk management platform | NASDAQ:TRHC | N/A | ~$1,300M EV | N/A | P |
| **trialcard** | Medication adherence and patient support | Odyssey Partners | N/A | ND (Nov-17) | LBO | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 23

## Pharmacy-Related Software and Services – Segmented

### Engagement and Marketing
*   aspen RxHealth
*   DIGITAL PHARMACIST
*   HealNow

### Rx Info and Risk Management
*   trc

### Specialty
*   Pharmetika

### At-Home Rx Delivery
*   alto
*   CAPSULE
*   Nimble
*   NowRx
*   Truepill

### Pharmacy Management Software
*   FDS
*   OmniSYS
*   RedSail TECHNOLOGIES™
*   Transaction Data Systems
*   BestRx PHARMACY SOFTWARE
*   CarePoint
*   Liberty

### Hospital Pharmacy
*   DrFirst.
*   trc
*   KITCHECK

### 340B
*   nuvem
*   RStrategies™
*   sentry data systems
*   CaptureRx
*   EQUISCRIPT
*   kalderos

### eRx
*   DrFirst
*   RXREVU

William Blair | 24

## Pharmacy-Related Software and Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **alto** | Digital pharmacy platform and medication delivery | Softbank, Greanoaks Capital Partners, Jackson Square Ventures | $358M | $250M (Jan-20) | 2020-$600M | VC |
| **aspen RxHealth** | Pharmacy patient engagement and medication management solutions | Bessemer Venture Partners, Flare Capital Partners | $36M | $27M (Dec-20) | 2020-$65M | VC |
| **BestRx PHARMACY SOFTWARE** | Pharmacy workflow management software for independent community pharmacies | N/A | N/A | N/A | N/A | |
| **CAPSULE** | Digital platform for home delivery of prescriptions | Durable Capital, T. Rowe Price, Baillie Gifford, TCV, G Squared | $590M | $300M (Apr-21) | 2021-$1B | VC |
| **CaptureRx** | 340B inventory and financial management software | N/A | N/A | N/A | N/A | |
| **CarePoint** | Pharmacy inventory management software | N/A | N/A | N/A | N/A | |
| **DIGITAL PHARMACIST** | Pharmacy digital communication and Rx adherence | K1 Investment Management | N/A | $125M EV (Mar-19) | LBO | PE |
| **DrFirst** | Solutions for ePrescribing, EPCS, and medication adherence | Sixth Street Partners, Goldman Sachs Private Capital, Savano Capital | $160M | $50M (May-21) | N/A | PE |
| **EQUISCRIPT** | 340B inventory management and engagement software | SSM Partners | N/A | ND (Nov-19) | N/A | PE |
| **FDS** | Pharmacy data warehousing | Calvert Street Capital Partners | N/A | ND (Aug-11) | LBO | PE |
| **HealNow** | SaaS-based customer onboarding and payments platform | Alabama Futures Fund, SoftBank | $1M | $1M (Dec-20) | N/A | VC |
| **kalderos** | Medicine management platform for coordination of drug discount programs | Bain Capital Ventures, Mercato Partners | $35M | $28M (Jun-20) | 2020-$126M | VC |
| **KITCHECK** | Automated hospital pharmacy kit and medication mgmt. software | Baxter Ventures, Kaiser Permanente | $38M | $15M (Jun-16) | 2016-$95M | VC |
| **Liberty** | Pharmacy management, point of sale, and multi-store management software | N/A | N/A | N/A | N/A | |
| **Nimble** | On-demand pharmacy platform to streamline workflow | Sequoia Capital, Four Rivers | $57M | $15M (Jan-18) | 2019-$115M | VC |
| **NowRx** | Prescription delivery network | Ulu Ventures, SeedInvest | $27M | $12M (Aug-19) | N/A | VC |
| **nuvem** | 340B software / services (eligibility, claims, accounting, audit) for covered entities | Parthenon Capital | N/A | ND (Jul-20) | N/A | PE |
| **OmniSYS** | Reimbursement, engagement, and business intelligence | Nexphase Capital | N/A | ND (Nov-13) | LBO | PE |
| **Pharmetika** | Specialty pharmacy workflow management software | N/A | N/A | N/A | N/A | |
| **RedSail TECHNOLOGIES™** | End-to-end solutions for community and long-term care pharmacies | Francisco Partners | N/A | ND (Mar-20) | LBO | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 25

## Pharmacy-Related Software and Services – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **RXREVU** | Prescription decision support platform for cost transparency and savings | JAZZ Venture Partners, Children's Hospital of Colorado | $28M | $7M (Jan-21) | 2021-$87M | VC |
| **RStrategies™** | SaaS administrative software for drug purchase and compliance for 340B | Renovus Capital Partners | N/A | ND (Sep-19) | LBO | PE |
| **sentry data systems** | Analytics, 340B compliance, and performance improvement | ABRY Partners | N/A | $200M EV (May-15) | LBO | PE |
| **trc** | Medication decision support solutions | Levine Leichtman | N/A | ND (Sep-17) | LBO | PE |
| **Transaction Data Systems** | Pharmacy management software | BlackRock, GTCR | N/A | ND (May-21) | LBO | PE |
| **Truepill** | Platform for healthcare brands that provides telehealth and pharmacy services | Oak HC/FT, Optum Ventures, Amity Ventures, Foundation Capital | $114M | $75M (Sep-20) | N/A | VC |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 26

## Drug Research & Development – Segmented

### R&D Services Marketplace
*   ISPECIMEN
*   Science EXCHANGE
*   scientist

### R&D Workflow Software
*   FLYWHEEL
*   labarchives
*   Benchling
*   Riffyn
*   tetrascience

### Digital Pathology
*   PAIGE
*   PathAl
*   PROSCIA

### Visualization / Bioinformatics
*   Insightful Science
*   dotmatics
*   ChemAxon
*   CDD.

### AI-Based R&D Solutions
*   Atomwise
*   BenevolentAI
*   Exscientia
*   insitro
*   PathAl
*   BenchSci
*   IKTOS
*   INSILICO MEDICINE
*   NURITAS
*   PAIGE
*   PROSCIA
*   VALO HEALTH

### Modeling / Biosimulation
*   CERTARA
*   Chemical Computing Group
*   GNS HEALTHCARE
*   SCHRÖDINGER.
*   S+ SimulationsPlus

William Blair | 27

## Drug Research & Development – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **Atomwise** | Drug discovery platform using AI to design new molecules | B Capital, Sanabil, Monsanto Growth, Baidu Ventures, Tencent | $174M | $123M (Aug-20) | 2020-$423M | VC |
| **Benchling** | Lab collaboration cloud software platform to accelerate R&D | Sequoia Capital, a16z, Thrive Capital, ICONIQ, F-Prime | $312M | $200M (Apr-21) | 2021-~$4B | VC |
| **BenchSci** | AI-based reagent and antibody selection software for experiment design | F-Prime, Gradient Ventures, Google AI Fund | $54M | $10M (Feb-21) | N/A | VC |
| **BenevolentAI** | Drug discovery and development platform | Temasek | $363M | $90M (Sep-19) | 2019-~$1B | VC |
| **CERTARA** | Biosimulation and regulatory writing consultancy | NASDAQ: CERT | N/A | ~$5,000M EV | N/A | P |
| **ChemAxon** | Assisted modeling and analytics tools for biochemistry | N/A | N/A | N/A | N/A | |
| **Chemical Computing Group** | Molecular modeling, simulation, and machine-learning software | Altaris | N/A | ND (Jun-17) | LBO | PE |
| **CDD.** | Data management software for drug discovery | Eli Lilly, Founders Fund, Bill & Melinda Gates Foundation | N/A | N/A | N/A | |
| **Exscientia** | AI tools for complex disease drug discovery | Softbank, Novo Holdings, Blackrock, Mubadala, Casdin Capital | $381M | $225M (Apr-21) | N/A | VC |
| **FLYWHEEL** | Data management and curation software for medical images | 8VC, Beringea, Tillman Venture | $32M | $21M (Feb-21) | N/A | VC |
| **GNS HEALTHCARE** | Big data analytics for precision medicine | Cigna Ventures, Celgene, Amgen Venures | $66M | $28M (Jan-20) | 2020-$148M | VC |
| **IKTOS** | SaaS platform for AI-driven drug design to create novel molecular structures | Bpifrance | $2M | $1M (Mar-18) | N/A | VC |
| **Insightful Science** | Research cycle software to streamline workflows (bioinformatics, visualization) | Insight Partners | N/A | ND (Nov-17) | LBO | PE |
| **Insilico Medicine** | Drug discovery engine for aging and age-related diseases | Baidu Ventures, F-Prime Ventures, Eight Roads | $61M | $37M (Aug-19) | N/A | VC |
| **insitro** | Machine learning technology for drug discovery and development | a16z, CPPIB, GV, T. Rowe, BlackRock | $643M | $400M (Mar-21) | 2021-$2.5B | VC |
| **ISPECIMEN** | Online cloud-based marketplace for human biospecimens | N/A | $17M | $6M (Jun-18) | N/A | VC |
| **labarchives** | Suite of SaaS solutions for research data, inventory, and resource management | N/A | N/A | N/A | N/A | |
| **NURITAS** | AI platform for natural peptide discovery | Cultivian Sandbox, Thrive Accelerator | $61M | $20M (Dec-17) | N/A | VC |
| **PAIGE** | AI platform for pathologist workflows (diagnosis, treatment, drug development) | KKR, Casdin Capital, J&J Innovation, Breyer Capital | $220M | $125M (Mar-21) | N/A | VC |
| **PathAl** | AI-powered research platform for cancer diagnosis and treatment | Kaiser Permanente, General Atlantic, LabCorp, BMS, Merck GHIF | $255M | $165M (May-21) | N/A | VC |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 28

## Drug Research & Development – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **PROSCIA** | Software platform for AI-powered workflows in pathology lab | Scale Venture Partners, Hitachi Ventures | $35M | $23M (Dec-20) | N/A | VC |
| **Riffyn** | Scientific development environment platform to improve scientific processes | Merck Ventures | $28M | $15M (May-19) | 2019-$53M | VC |
| **SCHRÖDINGER.** | Molecular modeling software for drug development | NASDAQ: SDGR | N/A | ~$4,800M EV | N/A | P |
| **Science EXCHANGE** | Online marketplace for R&D services | Maverick Ventures, Norwest Venture Partners | $74M | $20M (Oct-19) | 2019-$61M | VC |
| **scientist** | AI-powered online marketplace for medical research | Transformation Capital | $38M | $7M (Dec-19) | 2019-$122M | VC |
| **S+ SimulationsPlus** | Simulation and modeling software for pharmacology | NASDAQ: SLP | N/A | ~$1,200M EV | N/A | P |
| **tetrascience** | Cloud-based R&D data acquisition, management, harmonization, and enablement platform | Insight Partners, Alkeon Capital, Waters Corporation | $105M | $62M (Apr-21) | 2021-$212M | VC |
| **VALO HEALTH** | End-to-end platform utilizing ML and patient data to develop therapeutics | Koch Disruptive Technologies, PSP Investments, HBM Partners | $465M | $300M (Mar-21) | N/A | VC |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 29

## Pharma Supply Chain Management – Detail

| Company | Description | Relevant Investors | FTD | Last Round | PM | Type |
| :----------------------- | :---------------------------------------------------------------------- | :------------------------------------------- | :------ | :---------------- | :--------- | :--- |
| **APPRENTICE** | Augmented reality tools that optimize drug manufacturing processes | Insight Partners, Pritzker Group Venture Capital | $42M | $20M (Nov-20) | 2020-$105M | VC |
| **Knipper** | Pharmaceutical sample fulfillment and distribution service | Court Square Capital Partners | N/A | ND (Oct-19) | N/A | PE |
| **KALLIK** | Enterprise labeling for pharmaceutical and med device companies | FPE Capital | N/A | ND (Aug-19) | LBO | PE |
| **MEDISPEND** | Cloud-based HCP engagement and compliance management software for LS | Susquehanna Growth Equity | N/A | ND (May-21) | N/A | PE |
| **PARCELSHIELD** | Parcel management and rescue logistics solution for specialty pharmacies | Excellere Partners | $78M | $78M (Mar-20) | N/A | PE |
| **Qualio** | Quality management software for LS | Tiger Global, Storm Ventures, Sorenson Capital, MHS Capital Management | $67M | $50M (May-21) | N/A | VC |
| **tracelink** | SaaS SCM for LS | Georgian Partners, F-Prime, FirstMark Capital, Goldman Sachs | $174M | $93M (Aug-18) | 2018-$643M | VC |
| **TrakCel** | SCM software for cell / gene therapy | Telegraph Hill Partners, AmerisourceBergen, LabCorp | $8M | ND (Mar-21) | N/A | PE |
| **VALGENESIS** | Cloud-based validation lifecycle management solutions | Morgan Stanley Expansion Capital | $24M | $24M (May-21) | N/A | PE |
| **Veratrak** | Blockchain-based document collaboration and workflow management solutions | Force Over Mass Capital, Plug and Play Tech Center | $2M | $1M (Nov-20) | 2020-$9M | VC |
| **Vineti** | SCM software for cell / gene therapy | Cardinal Health, Novartis, GE Ventures, McKesson Ventures | $125M | $78M (Oct-20) | N/A | PE |

: Denotes public company or large strategic. : Denotes PE-backed company. : Denotes VC-backed or earlier-stage company.
Note: FTD = Funding to Date, PM = Post-Money. Source: Pitchbook, CapIQ, company websites, press releases, and William Blair proprietary intel.

William Blair | 30